NNE vs REGN · rev $84.0K vs P/E 14, rev $4.29B
Nano Nuclear Energy Inc. Common Stock (NNE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Nano Nuclear Energy Inc. Common Stock (NNE) is a specialty industrial machinery company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported NNE revenue for 2025-09-30 was $84.0K. Net income was -$40.1M. Revenue was up 1100.0% from 2024-09-30 to 2025-09-30. NNE currently screens at market cap $1.37B.
Latest reported REGN revenue for 2026-06-30 was $4.29B. Net income was $1.30B. Revenue was up 19.0% from 2026-03-31 to 2026-06-30. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
NNE currently screens at market cap $1.37B. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the NNE and REGN stock pages for the full models.
Not investment advice.